Molecular Docking and Cognitive Impairment Attenuating Effect of Phenolic Compound Rich Fraction of Trianthema portulacastrum in Scopolamine Induced Alzheimer’s Disease Like Condition
- 34 Downloads
Dementia is considered as the frequent cause of neurodegenerative mental disorder such as Alzheimer’s disease (AD) amongst elderly people. Free radicals as well as cholinergic deficit neurons within nucleus basalis magnocellularis demonstrated to attribute with aggregation of β amyloid which further acts as an essential hallmark in AD. Various phenolic phytoconstituents exists in Trianthema portulastrum (TP) leaves have been reported as active against various neurological disorders. The current investigation was undertaken to evaluate the antiamnesic potential of butanol fraction of TP hydroethanolic extract (BFTP) by utilizing rodent models of elevated plus maze (EPM) and Hebbs William Maze (HWM) along with in vitro and in vivo antioxidant as well as acetylcholinesterase (AChE) inhibition studies. Molecular docking studies were also performed for evaluation of molecular interaction of existed phenolic compounds in BFTP. In vitro antioxidant study revealed concentration dependant strong ability of BFTP to inhibit free radicals. In vitro AChE inhibition study showed competitive type of inhibition kinetics. BFTP significantly reversed (p < 0.005 versus scopolamine) the damaging effect of scopolamine by reducing TL (Transfer Latency) and TRC (Time taken to recognize the reward chamber) in the EPM and HWM, respectively. BFTP also contributed towards increased (p < 0.005 versus scopolamine) enzymatic antioxidant as well as hippocampal acetylcholine (ACh) levels. Histological studies also supported the results as BFTP pretreated mice significantly reversed the scopolamine induced histological changes in hippocampal region. Docking studies confirmed chlorogenic acid has the most significant binding affinity towards AChE. This research finding concludes that BFTP could be a beneficial agent for management of cognition and behavioral disorders associated with AD.
KeywordsLearning and memory Alzheimer’s disease Cognitive impairment Oxidative stress Chlorogenic acid Molecular docking
Authors are grateful to Dr Vikas Kumar, Department of Pharmaceutical Sciences, SHUATS for his generous help in histological studies. Authors extend their thanks to Dr Puhspraj Gupta, Department of Pharmaceutical Sciences, SHUATS for his support during in vivo studies. They also express their gratitude to Prof. R. M. Kadam, Head of Department, Department of Botany, Mahatma Gandhi Mahavidyalaya, Latur, Maharastra, India for his kind help in identification of plant material.
- 4.Dharmarajan TS, Gunturu SG (2009) Alzheimer’s disease: a healthcare burden of epidemic proportion. Am Health Drug Benefits 2:39–47Google Scholar
- 12.Williams RJ, Spencer JPE (2012) Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic Biol Med 52:35–45. https://doi.org/10.1016/j.freeradbiomed.2011.09.010 CrossRefGoogle Scholar
- 14.Yadav E, Singh D, Yadav P, Verma A (2017) Attenuation of dermal wounds via downregulating oxidative stress and inflammatory markers by protocatechuic acid rich n-butanol fraction of Trianthema portulacastrum Linn. in wistar albino rats. Biomed Pharmacother 96:86–97. https://doi.org/10.1016/j.biopha.2017.09.125 CrossRefGoogle Scholar
- 15.Mandal A, Bishayee A (2015) Trianthema portulacastrum Linn. displays anti-inflammatory responses during chemically induced rat mammary tumorigenesis through simultaneous and differential regulation of NF-κB and Nrf2 signaling pathways. Int J Mol Sci 16:2426–2445. https://doi.org/10.3390/ijms16022426 CrossRefGoogle Scholar
- 19.Tung BT, Hai NT, Thu DK (2017) Antioxidant and acetylcholinesterase inhibitory activities in vitro of different fraction of Huperzia squarrosa (Forst.) Trevis extract and attenuation of scopolamine-induced cognitive impairment in mice. J Ethnopharmacol 198:24–32. https://doi.org/10.1016/j.jep.2016.12.037 CrossRefGoogle Scholar
- 20.Sugimoto H, Iimura Y, Yamanishi Y, Yamatsu K (1995) Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds. J Med Chem 38:4821–4829. https://doi.org/10.1021/jm00024a009 CrossRefGoogle Scholar
- 26.Winterbourn CC, Hawkins RE, Brian M, Carrell RW (1975) The estimation of red cell superoxide dismutase activity. J Lab Clin Med 85:337–341Google Scholar
- 35.Youdim KA, Shukitt-Hale B, Joseph JA (2004) Flavonoids and the brain: interactions at the blood-brain barrier and their physiological effects on the central nervous system. Free Radic Biol Med 37:1683–1693. https://doi.org/10.1016/j.freeradbiomed.2004.08.002 CrossRefGoogle Scholar